Influence of polymer content in Ca-deficient hydroxyapatite- polycaprolactone nanocomposites on the formation of microvessel-like structures

Acta Biomaterialia

Volumn 6, Issue 8, 2010, Pages 3169-3177

  Fuchs, S ^a   Jiang, X ^a   Gotman, I ^b   Makarov, C ^b   Schmidt, H ^c   Gutmanas, E Y ^b   Kirkpatrick, C J ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c Meta Physiol   (Germany)

Author keywords

Angiogenesis; Bone; CDHA PCL; Co culture; Outgrowth endothelial cells

Indexed keywords

BIODEGRADABLE POLYMERS; BIOMECHANICS; CALCIUM PHOSPHATE; CONFOCAL MICROSCOPY; CYTOLOGY; ENDOTHELIAL CELLS; HYDROXYAPATITE; NANOCOMPOSITES; OSTEOBLASTS; POLYCAPROLACTONE; POLYMERASE CHAIN REACTION; TISSUE ENGINEERING;

ANGIOGENESIS; BONE REGENERATION; CA-DEFICIENT HYDROXYAPATITE-POLYCAPROLACTONE; CA-DEFICIENT HYDROXYAPATITES; CO-CULTURES; ENDOTHELIAL-CELLS; MICROVESSELS; OUTGROWTH ENDOTHELIAL CELL; POLYMER CONTENT; VASCULARIZATION;

BONE;

CALCIUM; CALCIUM PHOSPHATE CERAMIC; HYDROXYAPATITE; NANOCOMPOSITE; POLYCAPROLACTONE; POLYMER; ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; BIOMATERIAL; POLYESTER;

ARTICLE; BIOCOMPATIBILITY; BONE DEVELOPMENT; BONE REGENERATION; BONE TISSUE; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; COCULTURE; CONFOCAL MICROSCOPY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMAGE ANALYSIS; IMMUNOFLUORESCENCE; MICROVASCULATURE; MONOCULTURE; OSTEOBLAST; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TISSUE ENGINEERING; UMBILICAL VEIN; VASCULARIZATION; ANGIOGENESIS; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRASTRUCTURE;

ALKALINE PHOSPHATASE; BIOCOMPATIBLE MATERIALS; BIOLOGICAL MARKERS; CALCIUM; CELL PROLIFERATION; COCULTURE TECHNIQUES; DURAPATITE; ENDOTHELIAL CELLS; HUMANS; MICROVESSELS; NANOCOMPOSITES; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOBLASTS; POLYESTERS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77954537244     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2010.02.001     Document Type: Article

References (48)

1. Levenberg S, Rouwkema J, Macdonald M, Garfein ES, Kohane DS, Darland DC, et al. Engineering vascularized skeletal muscle tissue. Nat Biotechnol 2005;23:879-84.
2. Villars F, Guillotin B, Amedee T, Dutoya S, Bordenave L, Bareille R, et al. Effect of HUVEC on human osteoprogenitor cell differentiation needs heterotypic gap junction communication. Am J Physiol Cell Physiol 2002;282:C775-85.
3. Meury T, Verrier S, Alini M. Human endothelial cells inhibit BMSC differentiation into mature osteoblasts in vitro by interfering with osterix expression. J Cell Biochem 2006;98:992-1006.
4. Guillotin B, Bareille R, Bourget C, Bordenave L, Amedee J. Interaction between human umbilical vein endothelial cells and human osteoprogenitors triggers pleiotropic effect that may support osteoblastic function. Bone 2008;42:1080-91.
5. Kaigler D, Krebsbach PH, Polverini PJ, Mooney DJ. Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells. Tissue Eng 2003;9:95-103.
6. Clarke SA, Hoskins NL, Jordan GR, Marsh DR. Healing of an ulnar defect using a proprietary TCP bone graft substitute, JAX, in association with autologous osteogenic cells and growth factors. Bone 2007;40:939-47.
7. Ozturk A, Yetkin H, Memis L, Cila E, Bolukbasi S, Gemalmaz C. Demineralized bone matrix and hydroxyapatite/tri-calcium phosphate mixture for bone healing in rats. Int Orthop 2006;30:147-52.
8. Ignjatovic N, Uskokovic D. Synthesis and application of hydroxyapatite/polylactide composite biomaterial. Appl Surf Sci 2004;238:314-9.
9. Azevedo MC, Reis RL, Claase MB, Grijpma DW, Feijen J. Development and properties of polycaprolactone/hydroxyapatite composite biomaterials. J Mater Sci Mater Med 2003;14:103-7.
10. Neumann M, Epple M. Composites of calcium phosphate and polymers as bone substitution materials. Eur J Trauma 2006;32:125-31.
11. Unger RE, Sartoris A, Peters K, Motta A, Migliaresi C, Kunkel M, et al. Tissue-like self-assembly in cocultures of endothelial cells and osteoblasts and the formation of microcapillary-like structures on three-dimensional porous biomaterials. Biomaterials 2007;28:3965-76.
12. Santos MI, Unger RE, Sousa RA, Reis RL, Kirkpatrick CJ. Crosstalk between osteoblasts and endothelial cells co-cultured on a polycaprolactone-starch scaffold and the in vitro development of vascularization. Biomaterials 2009;30:4407-15.
13. Fuchs S, Jiang X, Schmidt H, Dohle E, Ghanaati S, Orth C, et al. Dynamic processes involved in the pre-vascularization of silk fibroin constructs for bone regeneration using outgrowth endothelial cells. Biomaterials 2009;30:1329-38.
14. Gulati R, Jevremovic D, Peterson TE, Chatterjee S, Shah V, Vile RG, et al. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 2003;93:1023-5.
15. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004;24:288-93.
16. Fuchs S, Hermanns MI, Kirkpatrick CJ. Retention of a differentiated endothelial phenotype by outgrowth endothelial cells isolated from human peripheral blood and expanded in long-term cultures. Cell Tissue Res 2006;326:79-92. (Pubitemid 44162540)
17. Fuchs S, Hofmann A, Kirkpatrick CJ. Microvessel-like structures from outgrowth endothelial cells from human peripheral blood in 2-dimensional and 3-dimensional co-cultures with osteoblastic lineage cells. Tissue Eng 2007;13:2577-88.
18. Fuchs S, Ghanaati S, Orth C, Barbeck M, Kolbe M, Hofmann A, et al. Contribution of outgrowth endothelial cells from human peripheral blood on in vivo vascularization of bone tissue engineered constructs based on starch polycaprolactone scaffolds. Biomaterials 2009;30:526-34.
19. Gutmanas EY. Cold sintering under high pressure-mechanisms and application. Powder Metall Int 1983;15:129-32.
20. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973;52:2745-56.
21. Hofmann A, Konrad L, Gotzen L, Printz H, Ramaswamy A, Hofmann C. Bioengineered human bone tissue using autogenous osteoblasts cultured on different biomatrices. J Biomed Mater Res A 2003;67:191-9.
22. Ang KC, Leong KF, Chua CK, Chandrasekaran M. Compressive properties and degradability of poly (ε-caprolatone)/hydroxyapatite composites under accelerated hydrolytic degradation. J Biomed Mater Res, Part A 2007; 80A: 655-60.
23. Rasband WS. Image J, vol. 2008. Bethesda, Maryland, USA: US National Institutes of Health; 1997-2007.
24. Rivron NC, Liu JJ, Rouwkema J, de Boer J, van Blitterswijk CA. Engineering vascularised tissues in vitro. Eur Cell Mater 2008;15:27-40.
25. Kirkpatrick CJ, Fuchs S, Hermanns MI, Peters K, Unger RE. Cell culture models of higher complexity in tissue engineering and regenerative medicine. Biomaterials 2007;28:5193-8.
26. Santos MI, Reis RL. Vascularization in bone tissue engineering: physiology, current strategies, major hurdles and future challenges. Macromol Biosci 2009;10:12-27.
27. Grellier M, Bordenave L, Amedee J. Cell-to-cell communication between osteogenic and endothelial lineages: implications for tissue engineering. Trends Biotechnol 2009;27:562-71.
28. Guillotin B, Bourget C, Remy-Zolgadri M, Bareille R, Fernandez P, Conrad V, et al. Human primary endothelial cells stimulate human osteoprogenitor cell differentiation. Cell Physiol Biochem 2004;14:325-32.
29. Elbjeirami WM, West JL. Angiogenesis-like activity of endothelial cells cocultured with VEGF-producing smooth muscle cells. Tissue Eng 2006.
30. Rouwkema J, de Boer J, Van Blitterswijk CA. Endothelial cells assemble into a 3-dimensional prevascular network in a bone tissue engineering construct. Tissue Eng 2006;12:2685-93.
31. Choong CS, Hutmacher DW, Triffitt JT. Co-culture of bone marrow fibroblasts and endothelial cells on modified polycaprolactone substrates for enhanced potentials in bone tissue engineering. Tissue Eng 2006.
32. Yu H, Van de Vord PJ, Mao L, Matthew HW, Wooley PH, Yang S-Y. Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization. Biomaterials 2009;30:508-17.
33. Kim HJ, Kim UJ, Vunjak-Novakovic G, Min BH, Kaplan DL. Influence of macroporous protein scaffolds on bone tissue engineering from bone marrow stem cells. Biomaterials 2005;26:4442-52.
34. Sang-Soo K, Min Sun P, Seung-Woo C, Sun Woong K, Kang-Min A, Jong-Ho L, et al. Enhanced bone formation by marrow-derived endothelial and osteogenic cell transplantation. J Biomed Mater Res Part A 2009;9999:NA.
35. Henrich D, Seebach C, Kaehling C, Scherzed A, Wilhelm K, Tewksbury R, Powerski M, Marzi I. Simultaneous cultivation of human endothelial like differentiated precursor cells and human marrow stromal cells on beta-Tricalciumphosphate. Tissue Eng Part C Methods 2009.
36. Dohle E, Fuchs S, Kolbe M, Hofmann S, Schmidt H, Kirkpatrick CJ. Sonic Hedgehog promotes angiogenesis and osteogenesis in a co-culture system consisting of primary osteoblasts and outgrowth endothelial cells. Tissue Eng C 2010; in press.
37. Cavallaro U, Liebner S, Dejana E. Endothelial cadherins and tumor angiogenesis. Exp Cell Res 2006;312:659-67.
38. Meinel L, Karageorgiou V, Hofmann S, Fajardo R, Snyder B, Li C, et al. Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds. J Biomed Mater Res A 2004;71:25-34. (Pubitemid 39244392)
39. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, et al. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990;143:420-30.
40. Sato M, Yasui N, Nakase T, Kawahata H, Sugimoto M, Hirota S, et al. Expression of bone matrix proteins mRNA during distraction osteogenesis. J Bone Miner Res 1998;13:1221-31.
41. Nakase T, Takaoka K, Hirakawa K, Hirota S, Takemura T, Onoue H, et al. Alterations in the expression of osteonectin, osteopontin and osteocalcin mRNAs during the development of skeletal tissues in vivo. Bone Miner 1994;26:109-22.
42. Komori T. Requisite roles of Runx-2 and Cbfb in skeletal development. J Bone Miner Metab 2003;21:193-7.
43. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997;89:747-54.
44. Guo H, Su J, Wei J, Kong H, Liu C. Biocompatibility and osteogenicity of degradable Ca-deficient hydroxyapatite scaffolds from calcium phosphate cement for bone tissue engineering. Acta Biomater 2009;5:268-78.
45. Kasten P, Vogel J, Luginbühl R, Niemeyer P, Tonak M, Lorenz H, et al. Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrier. Biomaterials 2005;26:5879-89.
46. Kasten P, Luginbühl R, van Griensven M, Barkhausen T, Krettek C, Bohner M, et al. Comparison of human bone marrow stromal cells seeded on calciumdeficient hydroxyapatite, [beta]-tricalcium phosphate and demineralized bone matrix. Biomaterials 2003;24:2593-603.
47. Yu HS, Jang JH, Kim TI, Lee HH, Kim HW. Apatite-mineralized polycaprolactone nanofibrous web as a bone tissue regeneration substrate. J Biomed Mater Res A 2009;88:747-54.
48. Yu H, Wooley PH, Yang SY. Biocompatibility of poly-epsilon-caprolactone- hydroxyapatite composite on mouse bone marrow-derived osteoblasts and endothelial cells. J Orthop Surg Res 2009;4:5.